TY - JOUR
T1 - After 9 Years of 3-Column Osteotomies, Are We Doing Better? Performance Curve Analysis of 573 Surgeries with 2-Year Follow-up
AU - Diebo, Bassel G.
AU - Lafage, Virginie
AU - Varghese, Jeffrey J.
AU - Gupta, Munish
AU - Kim, Han Jo
AU - Ames, Christopher
AU - Kebaish, Khaled
AU - Shaffrey, Christopher
AU - Hostin, Richard
AU - Obeid, Ibrahim
AU - Burton, Doug
AU - Hart, Robert A.
AU - Lafage, Renaud
AU - Schwab, Frank J.
N1 - Funding Information:
Dr Lafage holds a board membership with Nemaris Inc, grants from SRS, NIH, and Depuy, payment for lectures from Medicrea, Nemaris Inc, MSD, and Depuy, and stock/stock options with Nemaris Inc. Dr Varghese has Grants from SRS. Dr Gupta is a consultant and has other financial relationships with DePuy Synthes, other financial support with Johnson & Johnson, Pfizer, Pioneer, and Proctor & Gamble, and is a consultant with Medicrea. Dr Kim is a consultant for Biomet, K2M and Medtronic, and on the Speaker’s Bureau of DePuy Synthes. Dr Ames is a consultant with Medtronic and Stryker Spine, receives other financial support from Biomet and Stryker Spine, has grants/research support from DePuy Synthes, and is on the Speaker’s Bureau of Globus Medical. Dr Kebaish has grants/research support from DePuy Synthes, is a consultant with DePuy Synthes and K2M, and receives other financial support from DePuy Synthes, Orthofix, and SpineCraft. Dr Shaffrey is a consultant with Biomet, K2M, Medtronic, NuVasive, and Stryker, and receives other financial support from Biomet, Medtronic, and NnuVasive. Dr Hostin has grants/research support from DePuy Synthes and NuVasive and is a consultant with DePuy Synthes. Dr Obeid is a consultant with Alphatec Spine, DePuy Synthes, and Medtronic, has grants/research support from DePuy Synthes, and other financial support from Alphatec Spine. Dr Burton has grants/research support from, is a consultant for, and receives other financial support from DePuy Synthes. Dr Hart is a consultant for DePuy Synthes, Globus Medical, and Medtronic, is on the Speaker’s Bureau of DePuy Synthes, receives grants/research support from Medtronic, and other financial support from DePuy Synthes and Seaspine. Dr Schwab has a board membership with Nemaris Inc, is a consultant for MSD, Medicrea, and K2M, has grants from Depuy, MSD, and AO, has received payment for manuscript preparation from MSD, Nuvasive, Biomet, K2M, and Nemaris Inc, has patients with MSD, K2M, and Nemaris Inc, and receives royalties from MSD and K2M. The ISSG receives grants/research support from DePuy Synthes, Innovasis, Medtronic, and Stryker Spine.
Publisher Copyright:
© 2017 by the Congress of Neurological Surgeons.
PY - 2018/7/1
Y1 - 2018/7/1
N2 - BACKGROUND: In spinal deformity treatment, the increased utilization of 3-column (3CO) osteotomies refects greater comfort and better training among surgeons. This study aims to evaluate the longitudinal performance and adverse events (complications or revisions) for a multicenter group following a decade of 3CO. OBJECTIVE: To investigate if performance of 3CO surgeries improves with years of practice. METHODS: Patientswho underwent 3CO for spinal deformitywith intra/postoperative and revision data collected up to 2 yr were included. Patients were chronologically divided into 4 even groups. Demographics, baseline deformity/correction, and surgical metrics were compared using Student t-test. Postoperative and revision rates were compared using Chi-square analysis. RESULTS: Five hundred seventy-three patients were stratifed into: G1 (n = 143, 2004-2008), G2 (n = 142, 2008-2009), G3 (n = 144, 2009-2010), G4 (n = 144 2010-2013). The most recent patients were more disabled by Oswestry disability index (G4 = 49.2 vs G1 = 38.3, P =.001), and received a larger osteotomy resection (G4 = 26 vs G1 = 20, P =.011) than the earliest group. There was a decrease in revision rate (45%, 35%, 33%, 30%, P =.039), notably in revisions for pseudarthrosis (16.7% G1 vs 6.9% G4, P =.007). Major complication rates also decreased (57%, 50%, 46%, 39%, P =.023) as did excessive blood loss (>4 L, 27.2 vs 16.7%, P =.023) and bladder/bowel defcit (4.2% vs 0.7% P =.002). Successful outcomes (no complications or revision) signifcantly increased (P =.001). CONCLUSION: Over 9 yr, 3COs are being performed on an increasingly disabled population while gaining a greater correction at the osteotomy site. Revisions and complication rate decreased while success rate improved during the 2-yr follow-up period.
AB - BACKGROUND: In spinal deformity treatment, the increased utilization of 3-column (3CO) osteotomies refects greater comfort and better training among surgeons. This study aims to evaluate the longitudinal performance and adverse events (complications or revisions) for a multicenter group following a decade of 3CO. OBJECTIVE: To investigate if performance of 3CO surgeries improves with years of practice. METHODS: Patientswho underwent 3CO for spinal deformitywith intra/postoperative and revision data collected up to 2 yr were included. Patients were chronologically divided into 4 even groups. Demographics, baseline deformity/correction, and surgical metrics were compared using Student t-test. Postoperative and revision rates were compared using Chi-square analysis. RESULTS: Five hundred seventy-three patients were stratifed into: G1 (n = 143, 2004-2008), G2 (n = 142, 2008-2009), G3 (n = 144, 2009-2010), G4 (n = 144 2010-2013). The most recent patients were more disabled by Oswestry disability index (G4 = 49.2 vs G1 = 38.3, P =.001), and received a larger osteotomy resection (G4 = 26 vs G1 = 20, P =.011) than the earliest group. There was a decrease in revision rate (45%, 35%, 33%, 30%, P =.039), notably in revisions for pseudarthrosis (16.7% G1 vs 6.9% G4, P =.007). Major complication rates also decreased (57%, 50%, 46%, 39%, P =.023) as did excessive blood loss (>4 L, 27.2 vs 16.7%, P =.023) and bladder/bowel defcit (4.2% vs 0.7% P =.002). Successful outcomes (no complications or revision) signifcantly increased (P =.001). CONCLUSION: Over 9 yr, 3COs are being performed on an increasingly disabled population while gaining a greater correction at the osteotomy site. Revisions and complication rate decreased while success rate improved during the 2-yr follow-up period.
KW - Complication rate
KW - Revision rate
KW - Spinal deformity
KW - Spinal osteotomy
UR - http://www.scopus.com/inward/record.url?scp=85051324158&partnerID=8YFLogxK
U2 - 10.1093/neuros/nyx338
DO - 10.1093/neuros/nyx338
M3 - Article
C2 - 28973410
AN - SCOPUS:85051324158
SN - 0069-4827
VL - 83
SP - 69
EP - 75
JO - Clinical neurosurgery
JF - Clinical neurosurgery
IS - 1
ER -